SCHEMBL7300289

SCHEMBL7300289

COc1ccc(CSc2ccccc2NC(=O)Cc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.62
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
RAB9A P51151 1/20 0.60
SNCA P37840 1/20 0.58
L3MBTL1 Q9Y468 3/20 0.55
KMT2A Q03164 3/20 0.55
LMNA P02545 2/20 0.55
HPGD P15428 2/20 0.55
NPC1 O15118 1/20 0.55
ATM Q13315 1/20 0.55
KCNQ2 O43526 1/20 0.55
MEN1 O00255 2/20 0.52
CNR2 P34972 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7297699 0.87 MEN1 (0.61) MAPTALDH1A1SMN1; SMN2RAB9ASNCA
SCHEMBL7288495 0.84 KMT2A (0.70) ALDH1A1L3MBTL1KMT2ALMNAHPGD
SCHEMBL7761944 0.83 KMT2A (0.67) MAPTSMN1; SMN2RAB9ASNCAL3MBTL1
SCHEMBL7760879 0.78 MAPT (0.53) MAPTALDH1A1SMN1; SMN2RAB9ASNCA
SCHEMBL6169126 0.78 ALDH1A1 (0.80) MAPTALDH1A1SMN1; SMN2RAB9ASNCA
SCHEMBL8495430 0.77 MAPT (0.50) MAPTALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL7760034 0.76 MAPT (0.51) MAPTALDH1A1SMN1; SMN2RAB9AKMT2A
SCHEMBL6171613 0.76 RAB9A (1.00) MAPTALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL9370863 0.76 ALDH1A1 (0.88) MAPTALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL11357236 0.75 KMT2A (0.51) MAPTALDH1A1L3MBTL1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed